The Future of Work
AI Accelerates Drug Discovery, Shows Early Trial Success
In 2020, the drug DSP-1181 for Obsessive-Compulsive Disorder became the first AI-designed product to reach clinical trials, a project with Exscientia and Sumitomo Dainippon Pharma, according to ForkLo
Nolan Begay·May 18, 2026
